http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2504699-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_125f9fd20b43e12df366a0289f2124e8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-285 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2010-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c307f0b693033bf802831848d15fd434 |
| publicationDate | 2012-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2504699-A1 |
| titleOfInvention | Methods of detecting or monitoring activity of an inflammatory or neurodegenerative condition |
| abstract | An isolated aggrefatin protein elevated In multiple sclerosis patients as compared to healthy controls. Aggrefatin alone or in combination with other markers may be used as an indicator of an inflammatory condition and/or a neurodegenerative disease or condition such as multiple sclerosis, cancer, stroke, or other diseases. Aggrefatin alone or in combination with one or more other biomarkers may help monitor disease activity, detect a response to a therapy, or detect patient compliance with a therapy. |
| priorityDate | 2009-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 228.